chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt presented with approx 30-40 vesicles over face, extremities ad torso X 1 day. No fever. Father reports "new ones popping out".
Other anaphylactic react on 2013-08-28, clinician comment: This child has had each of the component vaccines before and did not have an immediate reaction this time.  Nevertheless, as patient started showing systemic allergic response within 24hrs of vaccination, adverse reaction to vaccines must be considered as possible cause of anaphylaxis.
Developed myocarditis - chest pains, shortness of breath, nausea, vomit,  possibly from the Moderna vaccine. No issues prior to this. Went through all Cardiac tests with all negative results.
Dizziness when gets up and with Movement, Initiating 3 weeks after Second Dose; This spontaneous case was reported by an other caregiver and describes the occurrence of DIZZINESS (Dizziness when gets up and with Movement, Initiating 3 weeks after Second Dose) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Dizziness when gets up and with Movement, Initiating 3 weeks after Second Dose). At the time of the report, DIZZINESS (Dizziness when gets up and with Movement, Initiating 3 weeks after Second Dose) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.     This case was linked to US-MODERNATX, INC.-MOD-2021-080389 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow-up information received on 20-MAY-2021 included additional medical history was added. On 21-Jul-2021: Follow-up received on 21-Jul-2021 contains non-significant information. Patient stated not to contact him.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080389:son case
Injection site started to itch, turned red and swollen. Applied a calendula cream to relieve itching. This lasted for 5 days. Redness and swelling dissappeared on sixth day, only slight itch remains.
headache, sore throat, fever-highest oral temp of 100.1, productive cough, chills, shortness of breath, body aches, sinus congestion, nasal congestion, post nasal drainage, chest congestion, chest tightness, chest pain, wheezing, patient is currently 16 weeks pregnant.
ALL THE OTHER FLU LIKE SYMPTOMS; FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced all the other flu like symptoms, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, headache and all the other flu like symptoms was not reported. This report was non-serious.
This spontaneous report was received from an office manager and refers to a 4-year-old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 30-NOV-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Suffered some side effects; Outside of recommended timeframe for second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Suffered some side effects) and PRODUCT DOSE OMISSION ISSUE (Outside of recommended timeframe for second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Suffered some side effects) and PRODUCT DOSE OMISSION ISSUE (Outside of recommended timeframe for second dose). At the time of the report, VACCINATION COMPLICATION (Suffered some side effects) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Outside of recommended timeframe for second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Infection; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 80-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration on 20Feb2021 as dose 1, single for COVID-19 immunization. Medical history included chronic obstructive pulmonary disease. No concomitant medication was reported. The patient has an infection currently, patient received first Pfizer COVID-19 vaccine dose 20Feb2021 and due for second dose on 27Mar2021. Patient was taking an antibiotic currently and wants to know go ahead and get the second dose or should wait. Patient hears that, some people saying the vaccine can affect your DNA - was this true and would it be beneficial to delay getting the second dose. Patient wants to know the percentages of people reporting side effects from the vaccine. The outcome of the event was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Associate received flu vaccine and Hepatitis B vaccine on 11/5/08 at approximately 3:30 pm. Associate called employee health office on 11/6/08 and stated she has multiple joint and body aches including legs, ankles, arm also experienced shooting pains up and down legs and behind ear. Denies fever. States "took Tylenol extra strength" with no relief of aches.
Client reports severe tenderness, warmth, and redness "beyond 4 hrs after receiving injection - currently has 12cm x 4cm area of induration "redness, warmth (3 days after injection) - has not used Tylenol, ibuprofen, benadryl , etc - no treatment, applied ice to R upper arm.
Individual received flu vaccine at approximately 1:10 PM in left deltoid muscle. Individual reported moderate numbness in left hand in the 4th and 5th digits. At 4:00 PM report mild numbness in same location. Instructed to call her physician.
2nd vaccine on Saturday.  Sunday, burning feet, leg, thigh.  Went to ER to check if it was cause by diabetes, was told its probably not Gulliam Barre. Still having the symptoms.  Worsen when laying down, better with movement.
Had mild rash around elbow which then extended to top near injection. A few times a day large hot blotches would erupt and be very itchy. Cold compresses helped. This lasted three days. One day 10 notices large lump under left arm. On day 11 had what seemed like 4 hives close together which gradually enlarged to a two inch circle. Over the next few days the rash extended upward from the circle in a half inch line. Intensely itchy. On day  13 noticed a lump under my right arm but much smaller than the one on the left arm.
Redness at injection site; Pain at injection site; Most painful shot; Chills, shivering; Shoulder pain; Painful arm movement; Fever; Felt nauseated; Tender, painful to touch; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 79-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included blood cholesterol increased and blood pressure high.   On 06-JAN-2023, the patient received the 1st dose of Shingrix (intramuscular, left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site erythema (Verbatim: Redness at injection site), injection site pain (Verbatim: Pain at injection site), pain (Verbatim: Most painful shot), chills (Verbatim: Chills, shivering), shoulder pain (Verbatim: Shoulder pain), pain in arm (Verbatim: Painful arm movement), fever (Verbatim: Fever), nausea (Verbatim: Felt nauseated) and tenderness (Verbatim: Tender, painful to touch).  The outcome of the injection site erythema, injection site pain, pain, chills, shoulder pain, pain in arm, fever, nausea and tenderness were recovered/resolved (duration 2 days).   It was unknown if the reporter considered the injection site erythema, injection site pain, pain, chills, shoulder pain, pain in arm, fever, nausea and tenderness to be related to Shingrix.     It was unknown if the company considered the injection site erythema, injection site pain, pain, chills, shoulder pain, pain in arm, fever, nausea and tenderness to be related to Shingrix.   Additional Information: GSK Receipt date: 03-Mar-2023 The reporter was a 79-year-old male.  The reporter reports he had his first dose of Shingrix vaccine.  Vaccine was provided at patient's primary care doctor's office.  The patient reports that he got the vaccine in the left arm and it was the most painful shot in my life. Patient reports having redness at injection site, pain at injection site, chills, shoulder pain, painful arm movement, fever, shivering, felt nauseated, tender to touch, and painful to touch.  The patient reports symptoms last for about 2 days. Patient reports he only takes medications for high blood pressure (HBP) and cholesterol. The reporter did not consent to follow-up. The reporter did not have all information was available.  Lot number and expiration date were unknown.
Child presented to office in the morning of 6/26 following a fussy night and emergence of red papules on face.  He started with 5 lesions and by the time he got to the office had 17 lesions on face and shoulders. He was afebrile on exam today and was otherwise well.  Today is day#21 following first varicella vaccine.
FATIGUE, FEVER 102 F, CHILLS, COUGH. HOSPITALIZED FOR 24 HRS.
Sick with fever and pain for several days. then rash developed which turned out to be shingles. I have had the shingles vaccine as well.
approx 3-3:30 pt exp tight sensation in throat;tx @ hosp ER;
STAFF INCORRECTLY FILLED OUT CONSENT FOR BOOSTER DOSE.  VACCINATION WAS 3RD DOSE  (0.25ML) BECAUSE IT WAS TOO EARLY FOR BOOSTER. PER CLIENT HAD ATTENDED COVID CLINIC IN JAN 2021, BUT INCORRECT INFORMATION WAS PROVIDED
PT IS A BREAKTHROUGH CASE OF COVID-19 THAT EXPIRED ON 9/1/2021.
The symptoms started with having a hard time breathing going jus down the stairs or to the car being short distances. As the week went on it suddenly got worse as now I am coughing profusely with a hard time breathing as if I am gasping for air. I have noticed it gets worst when the weather is rainy and dewy like, but when it is sunny and no storm like weather it seems to be better. Recently the as the weather changes my symptoms have gotten worst again. I cough so much that I vomit and now when I eat food I can not eat food with out coughing and it feels as if my throat is closing when I eat so I do not eat a lot of food. I did not have this issue before the vaccine and after I got the vaccine now I am having all of these issues.
In the weeks before September 26, 2021 I experienced extreme fatigue and extreme light headedness when I changed positions from laying, sitting, and standing up. On September 26, in my left ear, I suddenly experienced a long, very loud and unusually dramatic spell of tinnatus. It was above and beyond the usual, fairly constant, high pitched tinnatus that I had had for years in both ears. I  also suddenly became very weak and had to lay down. After 10 minutes I was able to stand up but I was wobbly and nauseous. After 1hr or so I became very nauseous and threw up. I fell asleep. When I woke up I realized I was completely deaf in my left ear. I was also very wobbly.
After the second dose I was a little sleepy and had some cold like symptoms. I got a little better, and then I got COVID-19 along with everyone in my house. I had congestion, body aches, diarrhea, and a fever. This lasted for about 2 weeks. We didn't go to the doctor, but we contacted them, and they told us what to do. My nose had been stuffy since being vaccinated and having COVID-19 and I went to the doctor, and they told me that my sinuses were swollen shut and I had to have a procedure done on 4/25/23, to open them back up.
In the evening of date patient got Pneumovax 23, her left arm got swollen and sore at the injection site. Patient has applied cold compress and taken tylenol as needed .  Her arm has slowly get better with time until today. The swelling has gone down and the pain has gone away.
Informed patient father to watch for local and systemic ADRs and to report to VAERS hotline.
Moderate nausea shortly after vaccination with a 2 hour duration.  Severe joint pain and burning beginning 28 hours after vaccination with a duration of 12 hours.
patient came in for his second dose of the Pfizer covid vaccine, patient stated on their intake form that the TDAP vaccine had caused him to faint in the past. after discussion with the patient, he stated that the first dose of the Pfizer vaccine did make him dizzy for a few minutes after the vaccine, but he did not faint following the first dose. After the first dose, because of his history with TDAP, patient was asked to stay for 30 minutes on site, after 30 minutes not further side effects other than the temporary dizziness. After that discussion it was decided to administer the second dose. Immediately after the dose, patient appeared to suffer from syncope, immediately becoming dazed and his eyes closing, within 1 to 2 minutes he became alert, aware of name and dob, etc. Patient's pulse and vitals were WNL. Offer was made to call ambulance for further evaluation, but patient declined. The pharmacist, remained with patient for 30 minutes to monitor, he continued to be fine.
Severe swelling & erythemia of the L deltoid. Pain developed~6pm - pt. unable to sleep due to pain level & vomiting pt. seen next am ice packs, Advil & Benadryl were prescribed. Pt. fully recovered on 10-8-09.
1553 received Moderna 2nd dose 1604 c/o nausea then hot feeling with heavy sweating 1612 138/89 80 VS monitored 1634 famotidine 20mg taken after Dr.  updated  VS monitored room temp turned down, fan provided, ice pack provided VS monitored  1716 135/86 76  1722 20mg famotidine taken 1740 emesis 1754 141/95 92 1755 ambulation steady, reports some feeling better, assisted to gather belongings and to meet friend for ride home VS/observations assisted RN, CNO/NM/DOP.
Presented with AMS and hypoxia. Tested positive PTA. Diagnosed with COVID-19 infection, resp failure and septic shock. He was placed on rate limiting medication and his rapid ventricular rate resolved. He was eventually weaned off oxygen and transferred out of the ICU. He completed antibiotics. His kidney function returned to normal. He is tolerating a diet. Palliative care consulted and his family decided to transition him to long-term care. The remainder of his medical problems were chronic and stable. He will be transferred. He is medically optimized for discharge. Discharged to long-term care.
Extreme dizziness. Could not drive, lay down or my eyes due to this intense dizziness. Finally went away after a couple hours but I still have a little dizzy spells the rest of the day.
muscle ache in the whole body; mild fever; fatigue; injection site muscle ache; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration in the left arm on 17Mar2021 at 09:30 am (at the age of 50-year-old), as a single dose for COVID-19 immunisation. Patient had no medical history. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication was not reported. On 17Mar2021 at 9:00 PM, the patient had experienced muscle ache in the whole body 12 hour after injection, mild fever with a temperature of 38.5 C, injection site muscle ache and fatigue. The patient had received ibuprofen for two days. It was reported that most symptoms improved 48 hours after injection. The clinical outcome of the events muscle ache in the whole body, injection site muscle ache, fatigue and fever were recovering at the time of the report. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: medical history added as none, vaccine dose information and narrative updated, event onset date for fever, injection site muscle pain and fatigue updated as 17Mar2021 09:00 pm.
Moderate arm pain 24-48 hours after vaccine.  Four days after vaccine, left axillary lymph nodes were swollen and painful and are just now starting to resolve.  Nine days after the vaccine, a large warm, red patch appeared on the skin over my left bicep extending to the tricep, measuring approximately 7 cm in diameter.  The red patch looked improved 24 hours later, but has become prominent again over the last 48-72 hours.
he's had swollen lymph nodes in groin area for about 4 months; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 32-year-old male patient received COVID-19 Vaccine - Manufacturer Unknown, in Sep2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 32 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, unknown manufacturer), for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset Sep2022, outcome "not recovered", described as "he's had swollen lymph nodes in groin area for about 4 months". The event "he's had swollen lymph nodes in groin area for about 4 months" required physician office visit.  Additional information: Reporter reported that his brother was fairly private about his health. His mom told him about his brother that he told her in confidence that he's had swollen lymph nodes in groin area for about 4 months. He told her it started about the time he got a COVID booster and he was wondering if it could be related. Guessing this was about Sep so likely the Bi-valent booster but I can't confirm this. Apparently, he was following up with a doctor now. As her told her in confidence and reporter did not even know if this was 3rd dose, booster or even the Pfizer brand vaccine for sure reporter don't want to had cold call to his brother about it. When possible he will try to get more details and ask him to follow up and keep this reference number to not double report the case.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
rash - rapid spreading; breathing problems, throat constriction.  Epi-Pen self-administered.  EMS called and transported with standard Benadryl via PO).
10 minutes after the vaccine was administered, she felt dizzy with headache & weakness of leg. The next day in school, she was confused and had to think hard about classroom location.
This spontaneous report was received from the patient's mother, concerning a female patient of currently 30 years old. The patient's historical condition, concurrent condition or allergies were not reported. The reporter states that her daughter, received doses of GARDASIL 9  (laterality, strength, dose, route, frequency, lot# and expiration date were not reported) all (as vaccination for prophylaxis) on 23-AUG-2008, 10-NOV-2008 and 16-MAR-2009. On an unknown date in May 2009, also reported as two months after finishing the series, the patient began having muscle spasms in her neck; which she experienced even under sedation (unspecified), and it had resulted in trouble breathing on numerous occasions, on unknown dates in 2009, the patient was approximately 21 years old at the time. It was reported that she has seen three neurologists, had magnetic resonance imaging's (MRI's) (dates an results were not provided) and been to pain care management. The patient also has been on an unspecified anti-seizure medication, massage therapy, physical therapy and had "spinal injections" (unspecified). It was reported that the patient's condition was currently not resolved. The causality assessment between GARDASIL 9 and the aforementioned events was not reported.